Competitors:
LGC
LGCSymbiomix Therapeutics Company Culture
Symbiomix Therapeutics Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterSymbiomix Therapeutics Company Information
Symbiomix Therapeutics Company Overview
Symbiomix Therapeutics is a Newark N.J.-based late-stage, privately held biopharmaceutical company
| Headquarter | 105 Lock Street, Suite 409 Newark, TX United States of America |
|---|---|
| Website | symbiomix.com |
| Founding Date | 2012 |
| Tel | 1(609) 722-7250 |
| Company Status | Private |
Symbiomix Therapeutics CEO & Leadership
Symbiomix Therapeutics CEO - David Stern
Symbiomix Therapeutics Leadership
David Stern CEO / President
David Stern serves as the CEO / President of Symbiomix Therapeutics.
Taunia Markvicka Chief Commercial Officer
Taunia Markvicka serves as the Chief Commercial Officer of Symbiomix Therapeutics, LLC. Taunia started at Symbiomix...
Symbiomix Therapeutics Careers
Symbiomix Therapeutics Jobs
No Recent Jobs found for Symbiomix Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Symbiomix Therapeutics Know You Want To Work There
Overview of Candidates Interested in Symbiomix Therapeutics on Comparably
Candidates By Department
All Industries | 100% |
|---|
Candidates By Location
Seattle | 100% |
|---|
Frequently Asked Questions regarding Symbiomix Therapeutics
What is Symbiomix Therapeutics address?
Symbiomix Therapeutics location is at 105 Lock Street, Suite 409
Who are Symbiomix Therapeutics competitors?
Symbiomix Therapeutics main competitors are LGC
Who is Symbiomix Therapeutics leadership?
Taunia Markvicka are part of Symbiomix Therapeutics leadership, David Stern is the CEO
×